However, consistent with several studies examining Zeb expression in lymphocytes and other immune cell populations (65), we were unable to confirm Zeb2 expression in BL cells, thus prompting us to explore roles for other miR-141 targets in EBV reactivation. This evidence concerns the gene ZEB1 and Burkitt lymphoma.